Of these, seven genes (BRIP1, ERCC4, FANCD2, FANCG, FANCI, MAD2L2, PPP2R2A) were previously related to the platinum sensitivity/resistance of different types of cancer cells, with NPEPPS being reported for the first time as a platinum drug sensitivity regulator. The gene discussed is ERCC4; the disease is cancer.